Panelists discusses how bronchiectasis differs from other respiratory diseases like asthma and COPD through symptoms, imaging findings, and pathophysiological mechanisms. Panelists discusses how the ...

Fibroepithelial polyps are benign tumours that usually arise from cutaneous or mucosal surfaces. In children they most commonly involve the skin, oral cavity, and genitourinary tract, whereas ...

The American College of Chest Physicians (CHEST) has released a new clinical guideline on the management of adult bronchiectasis. Published in the journal CHEST, the guideline contains 13 ...

A 28.8-day half-life is the number that matters most in the RESP-X Phase IIa readout — not because it is impressive on its own, but because it is precisely the pharmacokinetic lever that makes ...

If you have non-cystic fibrosis bronchiectasis, you’re likely an expert on the “lung side” of the disease — the stubborn mucus, the nagging cough, and the constant threat of a flare-up. But by causing ...

If you have bronchiectasis, the essential goal of treatment is to keep your airway clear. Bronchiectasis is a chronic lung condition in which the airways become widened and damaged, making it harder ...

DPP‑1 inhibitors and long‑term macrolides appeared to effectively reduce the frequency of exacerbations in patients with non-cystic fibrosis bronchiectasis compared with placebo, with macrolides ...

It started out as a typical hot yoga class for Lavonda. The North Carolina resident was used to strenuous workouts, but on this day in 2008 she felt faint as she went through the sequence of poses.

This activity is provided by National Jewish Health. Bronchiectasis is a complex and increasingly prevalent condition often overlooked in clinical practice, with frequent overlap with other ...

West Hartford man’s participation in UConn Health clinical trial leads to FDA-approval of first-ever medicine that he needs for his lung condition. It will be an extra special Thanksgiving for ...